Premium Nahrungsergänzungsmittel | artgerecht

Thraustochytrium sp. – DHA Source and Omega-3

Thraustochytrium sp. is a genus of marine microorganisms known for producing high amounts of DHA, an essential omega-3 fatty acid widely used in nutritional supplements and infant formula.

Regular tips about health Regular tips about health

Things worth knowing about "Thraustochytrium sp."

Thraustochytrium sp. is a genus of marine microorganisms known for producing high amounts of DHA, an essential omega-3 fatty acid widely used in nutritional supplements and infant formula.

What is Thraustochytrium sp.?

Thraustochytrium sp. refers to a genus of unicellular, marine microorganisms belonging to the group known as thraustochytrids. Taxonomically classified within the Stramenopiles, these organisms are neither true fungi nor algae, although they share superficial similarities with both groups. They are found worldwide in marine and brackish water environments, colonizing organic matter such as decaying seagrasses and mangrove leaves.

These microorganisms are of particular interest due to their remarkable ability to produce large quantities of polyunsaturated fatty acids (PUFAs), especially docosahexaenoic acid (DHA), an omega-3 fatty acid that is essential for human health.

Biological Characteristics

Thraustochytrium sp. displays several distinctive biological features that set it apart from other microorganisms:

Unicellular, heterotrophic organism with a unique ectoplasmic network used for nutrient absorption
Rapid growth on organic carbon sources such as glucose
High lipid accumulation: up to 50-70% of dry cell weight may consist of lipids
Tolerance to varying salinity levels and temperatures
Reproduction via non-motile spores as well as flagellated zoospores

Mechanism of Action and Fatty Acid Production

The biosynthesis of DHA in Thraustochytrium sp. occurs via two main pathways: the classical fatty acid synthase and desaturase/elongase pathway, and the polyketide synthase (PKS)-like pathway, also known as the PUFA synthase pathway. The latter enables highly efficient production of long-chain polyunsaturated fatty acids without requiring the numerous desaturation steps typical of classical fatty acid synthesis.

The produced omega-3 fatty acids are stored in lipid bodies within the cell and can be harvested in large quantities through controlled fermentation processes.

Biotechnological and Medical Applications

Thraustochytrium sp. is extensively used as a sustainable, plant-based source of DHA in the biotechnology industry. Key areas of application include:

Dietary supplements: DHA derived from thraustochytrids is commercially available as a plant-based alternative to fish oil capsules, suitable for vegans and individuals with fish allergies.
Infant formula: Microbial DHA from Thraustochytrium sp. is added to infant formula to support brain and eye development in newborns.
Aquaculture: Used as DHA-rich feed supplements for fish and marine animals to replicate the natural omega-3 content found in wild-caught seafood.
Pharmaceutical research: Investigation of DHA-rich extracts for potential anti-inflammatory and cardioprotective effects.

Health Significance of DHA

Docosahexaenoic acid (DHA) is an essential omega-3 fatty acid that the human body can only synthesize in limited amounts. It is a critical structural component of cell membranes, particularly in the brain and the retina of the eye. Adequate DHA intake has been associated with:

Support of cognitive development in infants and children
Reduced risk of cardiovascular disease
Anti-inflammatory properties
Potential protective effects against neurodegenerative diseases

Safety and Regulation

DHA oil derived from Thraustochytrium sp. is authorized in the European Union and other countries as a novel food and is considered safe for human consumption. The European Food Safety Authority (EFSA) has conducted comprehensive safety assessments and approved its use in food products and dietary supplements.

References

European Food Safety Authority (EFSA): Safety of DHA-rich oil from Thraustochytrium sp. as a novel food. EFSA Journal, 2014.
Raghukumar, S.: Thraustochytrid marine protists: production of PUFAs and other emerging technologies. Marine Biotechnology, 2008.
Barclay, W.R. et al.: Heterotrophic production of long chain omega-3 fatty acids utilizing algae and algae-like microorganisms. Journal of Applied Phycology, 1994.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.